← Back to Search

Ketone Monoester

BHB supplement for High Blood Pressure (BHB Trial)

N/A

Waitlist Available

Led By Eléonor Riesco, PhD

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours

Awards & highlights

BHB Trial Summary

This trial will assess whether acute consumption of a ketone monoester supplement can lower blood pressure and improve glucose control in healthy adults.

BHB Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in blood pressure and ambulatory blood pressure

Effect on glucose homeostasis

Secondary outcome measures

Changes in IL-10 inflammatory profile

Changes in transcriptomic analyses of peripheral blood mononuclear cells

BHB Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: BHB supplement conditionExperimental Treatment1 Intervention

Group II: Placebo solution conditionPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor

292 Previous Clinical Trials

69,426 Total Patients Enrolled

University of British ColumbiaOTHER

1,413 Previous Clinical Trials

2,466,946 Total Patients Enrolled

Eléonor Riesco, PhDPrincipal InvestigatorUniversité de Sherbrooke

Media Library

BHB supplement (Ketone Monoester) Clinical Trial Eligibility Overview. Trial Name: NCT05794802 — N/A

High Blood Pressure Research Study Groups: Placebo solution condition, BHB supplement condition

High Blood Pressure Clinical Trial 2023: BHB supplement Highlights & Side Effects. Trial Name: NCT05794802 — N/A

BHB supplement (Ketone Monoester) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05794802 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are currently enrolling volunteers for this research program?

"Affirmative, clinicaltrials.gov reveals that this particular trial is not accepting new participants at the present moment. It was initially posted on June 1st 2023 and last modified on March 20th of the same year; however, there are 109 other trials seeking patients currently."

Answered by AI

Does this study offer enrollment to octogenarian participants?

"This research is seeking individuals aged between 20 and 45 years old."

Answered by AI

Is it possible to join this medical experiment?

"Participation in this clinical trial necessitates that applicants have elevated blood pressure and are within the age range of 20-45. A total of 15 individuals need to be enlisted."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ketone Monoester and Blood Pressure

2023. "Ketone Monoester and Blood Pressure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05794802.